Search references for TESTOLACTONE. Phrases containing TESTOLACTONE
See searches and references containing TESTOLACTONE!TESTOLACTONE
Chemical compound
Testolactone (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name) (brand name Teslac) is a non-selective, irreversible
Testolactone
Medical condition
steroidogenesis, such as cyproterone acetate, ketoconazole, spironolactone, and testolactone. Alternatively, the combination of the androgen receptor antagonist bicalutamide
Familial male-limited precocious puberty
Familial_male-limited_precocious_puberty
Chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Fluorouracil
American professional wrestler (1963–2025)
memoir, Brunk identified his own pills specifically as nine tablets of testolactone, an anti-estrogen drug, and wrote that Van Dam was separately found with
Sabu_(wrestler)
Index of chemical compounds with the same molecular formula
Methoxyestrones 2-Methoxyestrone 4-Methoxyestrone Pirnabine Prallethrin Testolactone This set index page lists chemical structure articles associated with
C19H24O3
American professional wrestler (born 1970)
while Brunk was in possession of drug paraphernalia and nine tablets of testolactone. Both Szatkowski and Brunk were released after posting bail, and were
Rob_Van_Dam
Chemical compound; chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Vincristine
anastrozole, letrozole, aminoglutethimide, exemestane, formestane, and testolactone are banned. Selective estrogen receptor modulators, including raloxifene
List of drugs banned by the World Anti-Doping Agency
List_of_drugs_banned_by_the_World_Anti-Doping_Agency
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Bortezomib
Breast cancer drug
inhibitors Generation Medication Dosage % inhibitiona Classb IC50c First Testolactone 250 mg 4x/day p.o. ? Type I ? 100 mg 3x/week i.m. ? Rogletimide 200 mg
Letrozole
Indian federal government rules
Examples of substances under this schedule: All insulin preparations, testolactone, hydroxyurea, daunorubicin, metformin, diphenhydramine, carbutamide,
Drugs and Cosmetics Rules, 1945
Drugs_and_Cosmetics_Rules,_1945
Common side effects in chemotherapy treatment
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Chemotherapy-induced nausea and vomiting
Chemotherapy-induced_nausea_and_vomiting
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Camptothecin
Enzyme used as medication and in food manufacturing
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Asparaginase
Drugs that are useful against cancer
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
List of chemotherapeutic agents
List_of_chemotherapeutic_agents
Class of drugs
inhibitors (AIs) include: Aminoglutethimide (Elipten, Cytadren, Orimeten) Testolactone (Teslac) Anastrozole (Arimidex) Letrozole (Femara) Exemestane (Aromasin)
Aromatase_inhibitor
Gender-affirming medical treatment
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Gender-affirming hormone therapy
Gender-affirming_hormone_therapy
Drug for treatment of breast cancer
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Utidelone
Primary female sex hormone
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Estrogen
Chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Doxorubicin
Pharmaceutical drug
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Oxaliplatin
Chemical compound and pharmaceutical drug
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Cisplatin
U.S. health institute
Fluoxymesterone (Halotestin) (1958) Dromostanolone (Drolban) (1961) Testolactone (Teslac) (1970) Methyl prednisolone Prednisolone Zoladex (1989) Biologicals
National_Cancer_Institute
Chemical compound
inhibitors Generation Medication Dosage % inhibitiona Classb IC50c First Testolactone 250 mg 4x/day p.o. ? Type I ? 100 mg 3x/week i.m. ? Rogletimide 200 mg
Anastrozole
Type of gender-affirming medical treatment
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Feminizing_hormone_therapy
Pharmaceutical drug classification
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
ATC_code_L01
Chemotherapy and immunosuppressant medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Methotrexate
Gene therapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Obecabtagene_autoleucel
Group of stereoisomers
and led to the development of other aromatase inhibitors. Along with testolactone, it is described as a "first-generation" aromatase inhibitor. AG has
Aminoglutethimide
Chemical that inhibits the use of a metabolite
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Antimetabolite
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Gemcitabine
Medical treatment for low fertility
indication for use of aromatase inhibitors improving spermatogenesis, testolactone has been shown to be effective when compared to placebo. Though there
Fertility_medication
Substance that modifies the effects of sex hormones
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Sex-hormonal_agent
Class of drugs
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Antiestrogen
Chemical compound
not require aromatization of testosterone: a study using tamoxifen, testolactone, and dihydrotestosterone". Archives of Sexual Behavior. 14 (6): 539–548
Dihydrotestosterone undecanoate
Dihydrotestosterone_undecanoate
Pharmaceutical drug
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Cladribine
Group of antibiotics
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Mitomycins
Industrial chemical and medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Arsenic_trioxide
secretion and stimulate ovaries and that causes rise in estrogen levels. Testolactone and formestane are 1st and 2nd generation aromatase inhibitors. Formestane
Steroidal_aromatase_inhibitor
Glycopeptide antibiotic used to treat various cancers
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Bleomycin
Nonsteroidal anti-inflammatory medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Celecoxib
Chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Dacarbazine
Chemical compound
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Dienestrol
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Capecitabine
Chemical compound
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Imlunestrant
Gene therapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Idecabtagene_vicleucel
Medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Hydroxycarbamide
Anti-breast cancer medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Abemaciclib
Gene therapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Talimogene_laherparepvec
Pharmaceutical drug
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Verteporfin
Hormone therapy used to treat symptoms of menopause
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Hormone_replacement_therapy
Gene therapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Lisocabtagene_maraleucel
Chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Vinblastine
Human glycoprotein that binds to androgens and estrogens
Steroidal 0.03 0.37 <0.1 <0.1 Tamoxifen Nonsteroidal <0.01 <0.2 <0.1 <0.1 Testolactone Steroidal <0.01 <0.2 <0.1 <0.1 Testosterone Steroidal 100 1600 8.3 5
Sex_hormone–binding_globulin
Class of antimetabolite medications
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Antifolate
Form of hormonal contraception combining both an estrogen and a progestogen
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Combined hormonal contraception
Combined_hormonal_contraception
Form of phototherapy
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Photodynamic_therapy
Combination drug
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Ethinylestradiol/cyproterone acetate
Ethinylestradiol/cyproterone_acetate
Drug class
(AIs) such as aminoglutethimide, anastrozole, exemestane, letrozole, and testolactone inhibit the production of estrogens from androgens and are used mainly
Steroidogenesis_inhibitor
Chemical compound
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Estradiol_valerate
Pharmaceutical combination
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Conjugated estrogens/medroxyprogesterone acetate
Conjugated_estrogens/medroxyprogesterone_acetate
Class of drugs used to treat malignant tumors
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Antineoplastic
Medication used as chemotherapy and to suppress the immune system
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Cyclophosphamide
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Exatecan
Medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Tretinoin
Medication used to treat cancer
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Carboplatin
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Dactinomycin
Medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Lifileucel
Medication used for cancer
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Paclitaxel
Cancer drug
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Protein-bound_paclitaxel
Chemotherapy medication used for several cancer types
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Procarbazine
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Talazoparib
Breast cancer medication
inhibitors Generation Medication Dosage % inhibitiona Classb IC50c First Testolactone 250 mg 4x/day p.o. ? Type I ? 100 mg 3x/week i.m. ? Rogletimide 200 mg
Exemestane
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Mercaptopurine
Chemical compound (chemotherapy medication)
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Cytarabine
Steroidal hormone medication
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Estradiol_(medication)
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Carmustine
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Ribociclib
Type of hormone replacement therapy with unclear efficacy
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Bioidentical hormone replacement therapy
Bioidentical_hormone_replacement_therapy
Endogenous non-proteinogenic amino acid
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Aminolevulinic_acid
Class of taxanes
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Taxuspines
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Lomustine
another study with a similar design that used the aromatase inhibitor testolactone. Men with aromatase deficiency and estrogen insensitivity syndrome, and
Effects of hormones on sexual motivation
Effects_of_hormones_on_sexual_motivation
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Chlormethine
Cell based gene therapy
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Brexucabtagene_autoleucel
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Chlorambucil
Chemical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Pelabresib
Medical condition
clomiphene citrate (an antiestrogen) and aromatase inhibitors such as testolactone or anastrozole have shown effectiveness in benefiting spermatogenesis
Male_infertility
Cancer medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Temozolomide
Medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Venetoclax
Estrogen administered intervaginally
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Vaginal_estrogen
Chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Etoposide
Chemotherapy medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Docetaxel
Pharmaceutical drug
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Tebentafusp
Medical condition
mediated by aromatase and can be inhibited by aromatase blockers such as testolactone. Blocking the effects and conversions of estrogens will allow the use
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency
Pharmaceutical compound
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Entinostat
Chemical compound
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Estradiol_enanthate
Medication
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
Decitabine/cedazuridine
Infertility treatment for women
Trilostane Aromatase inhibitors First-generation: Aminoglutethimide Testolactone Second-generation: Fadrozole Formestane Third-generation: Anastrozole
Clomifene
Chemotherapy regimen
antagonists ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone) Cell therapy and Gene therapy Axicabtagene ciloleucel Brexucabtagene
CBV_(chemotherapy)
travel, tourism, insurance
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
TESTOLACTONE
travel, tourism, insurance